Pharmaceutical compositions of metabotropic glutamate 5 receptor (MGLU5) antagonists

Pharmaceutical compositions of metabotropic glutamate 5 receptor (MGLU5) antagonists

Pharmaceutical compositions of metabotropic glutamate 5 receptor (mGlu5) antagonists or a pharmacologically acceptable salt thereof are disclosed. The compositions contain the therapeutic active compound with non-ionic polymer and ionic polymer, binder and fillers in either matrix pellet, matrix tab...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HUANG JINGJUN, SHAH NAVNIT HARGOVINDAS, LINDENSTRUTH KAI, KOENNINGS STEPHANIE, CHATTERJI ASHISH, SANDHU HARPREET K
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HUANG JINGJUN
SHAH NAVNIT HARGOVINDAS
LINDENSTRUTH KAI
KOENNINGS STEPHANIE
CHATTERJI ASHISH
SANDHU HARPREET K
description Pharmaceutical compositions of metabotropic glutamate 5 receptor (mGlu5) antagonists or a pharmacologically acceptable salt thereof are disclosed. The compositions contain the therapeutic active compound with non-ionic polymer and ionic polymer, binder and fillers in either matrix pellet, matrix tablet or coated pellets. The compositions provide a pH-independent in vitro release profile with NMT 70% in one hour, NMT 85% in 4 hour, and NLT 80% in 8 hours. The compositions are useful for the treatment of CNS disorders, such as Treatment-Resistant Depression (TRD) and Fragile X Syndrome.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN105012301A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN105012301A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN105012301A3</originalsourceid><addsrcrecordid>eNqNzT0KAjEQQOE0FqLeYey0EBKXHEAWfwoVi7VexjC7BpJMSGbvr4UHsHrNB2-uuscbS0RHk3iHARzHzNWL51SBB4gk-GIpnL2DMUyCEYXAQiFHWbjA5na-Pu0WMAmOnHyVulSzAUOl1a8LtT4du_ayo8w91fzdJZK-vRtttdk32hyaf8wHpH84gA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pharmaceutical compositions of metabotropic glutamate 5 receptor (MGLU5) antagonists</title><source>esp@cenet</source><creator>HUANG JINGJUN ; SHAH NAVNIT HARGOVINDAS ; LINDENSTRUTH KAI ; KOENNINGS STEPHANIE ; CHATTERJI ASHISH ; SANDHU HARPREET K</creator><creatorcontrib>HUANG JINGJUN ; SHAH NAVNIT HARGOVINDAS ; LINDENSTRUTH KAI ; KOENNINGS STEPHANIE ; CHATTERJI ASHISH ; SANDHU HARPREET K</creatorcontrib><description>Pharmaceutical compositions of metabotropic glutamate 5 receptor (mGlu5) antagonists or a pharmacologically acceptable salt thereof are disclosed. The compositions contain the therapeutic active compound with non-ionic polymer and ionic polymer, binder and fillers in either matrix pellet, matrix tablet or coated pellets. The compositions provide a pH-independent in vitro release profile with NMT 70% in one hour, NMT 85% in 4 hour, and NLT 80% in 8 hours. The compositions are useful for the treatment of CNS disorders, such as Treatment-Resistant Depression (TRD) and Fragile X Syndrome.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20151104&amp;DB=EPODOC&amp;CC=CN&amp;NR=105012301A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20151104&amp;DB=EPODOC&amp;CC=CN&amp;NR=105012301A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HUANG JINGJUN</creatorcontrib><creatorcontrib>SHAH NAVNIT HARGOVINDAS</creatorcontrib><creatorcontrib>LINDENSTRUTH KAI</creatorcontrib><creatorcontrib>KOENNINGS STEPHANIE</creatorcontrib><creatorcontrib>CHATTERJI ASHISH</creatorcontrib><creatorcontrib>SANDHU HARPREET K</creatorcontrib><title>Pharmaceutical compositions of metabotropic glutamate 5 receptor (MGLU5) antagonists</title><description>Pharmaceutical compositions of metabotropic glutamate 5 receptor (mGlu5) antagonists or a pharmacologically acceptable salt thereof are disclosed. The compositions contain the therapeutic active compound with non-ionic polymer and ionic polymer, binder and fillers in either matrix pellet, matrix tablet or coated pellets. The compositions provide a pH-independent in vitro release profile with NMT 70% in one hour, NMT 85% in 4 hour, and NLT 80% in 8 hours. The compositions are useful for the treatment of CNS disorders, such as Treatment-Resistant Depression (TRD) and Fragile X Syndrome.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzT0KAjEQQOE0FqLeYey0EBKXHEAWfwoVi7VexjC7BpJMSGbvr4UHsHrNB2-uuscbS0RHk3iHARzHzNWL51SBB4gk-GIpnL2DMUyCEYXAQiFHWbjA5na-Pu0WMAmOnHyVulSzAUOl1a8LtT4du_ayo8w91fzdJZK-vRtttdk32hyaf8wHpH84gA</recordid><startdate>20151104</startdate><enddate>20151104</enddate><creator>HUANG JINGJUN</creator><creator>SHAH NAVNIT HARGOVINDAS</creator><creator>LINDENSTRUTH KAI</creator><creator>KOENNINGS STEPHANIE</creator><creator>CHATTERJI ASHISH</creator><creator>SANDHU HARPREET K</creator><scope>EVB</scope></search><sort><creationdate>20151104</creationdate><title>Pharmaceutical compositions of metabotropic glutamate 5 receptor (MGLU5) antagonists</title><author>HUANG JINGJUN ; SHAH NAVNIT HARGOVINDAS ; LINDENSTRUTH KAI ; KOENNINGS STEPHANIE ; CHATTERJI ASHISH ; SANDHU HARPREET K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN105012301A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>HUANG JINGJUN</creatorcontrib><creatorcontrib>SHAH NAVNIT HARGOVINDAS</creatorcontrib><creatorcontrib>LINDENSTRUTH KAI</creatorcontrib><creatorcontrib>KOENNINGS STEPHANIE</creatorcontrib><creatorcontrib>CHATTERJI ASHISH</creatorcontrib><creatorcontrib>SANDHU HARPREET K</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HUANG JINGJUN</au><au>SHAH NAVNIT HARGOVINDAS</au><au>LINDENSTRUTH KAI</au><au>KOENNINGS STEPHANIE</au><au>CHATTERJI ASHISH</au><au>SANDHU HARPREET K</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pharmaceutical compositions of metabotropic glutamate 5 receptor (MGLU5) antagonists</title><date>2015-11-04</date><risdate>2015</risdate><abstract>Pharmaceutical compositions of metabotropic glutamate 5 receptor (mGlu5) antagonists or a pharmacologically acceptable salt thereof are disclosed. The compositions contain the therapeutic active compound with non-ionic polymer and ionic polymer, binder and fillers in either matrix pellet, matrix tablet or coated pellets. The compositions provide a pH-independent in vitro release profile with NMT 70% in one hour, NMT 85% in 4 hour, and NLT 80% in 8 hours. The compositions are useful for the treatment of CNS disorders, such as Treatment-Resistant Depression (TRD) and Fragile X Syndrome.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_CN105012301A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Pharmaceutical compositions of metabotropic glutamate 5 receptor (MGLU5) antagonists
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A35%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HUANG%20JINGJUN&rft.date=2015-11-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN105012301A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true